Long Term Results of Small Diameter 12-16 mm Contegra Conduit for Right Ventricular Outflow Tract Reconsruction

Eli Levy 1 Julius Golender 2 Eli Milgalter 1 Bisher Marzouqa 1 Nael El-lahham 2 Murar Ayman 1 Eldad Erez 1 Oz M. Shapira 1 Azaria JTT Rein 2
1cardiothoracic surgery, Hadassah medical center, Jerusalem, Israel
2pediatric cardiology, Hadassah medical center, Jerusalem, Israel

The Contegra conduit which is a bovine internal jugular vein

 

with a valve, is used for reconstruction of the right ventricular

 

outflow tract in congenital cardiac malformations. We hereby

 

describe the long term results of using a small diameter 12-16

 

mm Contegra conduits.

 

 

Methods

 

From October 2000 to May 2014 we have operated on 39

 

patients that Contegra conduits were used for reconstructing

 

their right ventricular outflow tract. Eighteen were males and 21            

 

females at mean age of 2.1 +- 2.8 years (range from 13 days      

 

to 13 years). Twenty four patients had 12 mm Contegra, nine

 

patients had 14 mm, and six patients had 16 mm.

 

One patient was a tourist, and was lost for follow up.

 

The mean follow up period for all the other 38 patients was

 

7 +- 4 years (range 7 months - 14 years).

 

                                

 

Results

 

There was one perioperative death (2.5%). There were 5 late

 

deaths (13%), with a mean interval of six months from the

 

time of the operation (range 4 months-9 months). Only one

 

death seems to be related to the Contegra, due to early failure.

 

The survival rate at 5 and 10 years was 87+-4 and 84+- 3%          

 

respectively. Three patients needed re-operation for Contegra

 

stenosis at mean interval of 7 years (range 3-11 years). They

 

had replacement of their Contegra with a larger diameter of the

 

same conduit. The re-operations were done without mortality.

 

The rate of freedom from re-operation at 5 and 10 years was

 

93+- 3 and 90 +- 4% respectively.                

 

There were two cases of bacterial endocarditis (5%) treated with

 

antibiotics only.                        

 

 

Conclusions

 

The usage of the Contegra conduit is safe and reproducible.

 

The Contegra conduit is “ready on the shelf” product, available

 

In small diameters of 12-16 mm which are the most challenging

 

sizes in congenital cardiac surgery. We found a low rate of

 

bacterial endocarditis treated with antibiotics only, and a low

 

rate of periopertive mortality.

 

The good survival rate at 5 and 10 years, the freedom from re-

 

operation and the much cheaper price of Contegra compare to

 

homograft, which is the only other option in these diameters,

 

makes it an attractive option when dealing with right ventricular

 

outflow tract reconstruction.    

 









Powered by Eventact EMS